CL
Core Laboratories
CLB · NYSE
$12.50 -0.24% (-$0.03)
1M -0.95%
Market Cap $577.1M
P/E Ratio 23.70x
Div. Yield 0.32%
ROE 9.03%
Bulios Fair Price
$6.59
47.3% downside
Trenutna cena
$12.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CLB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
36 /100
Fair P/E 23.70x
P/B 2.12x
EV/EBITDA 11.48x
Growth
79 /100
Growing EPS growth 17.42%
Book val. growth 14.94%
Rev. growth 2.44%
Profitability
49 /100
Moderate Gross margin 18.12%
FCF margin 2.07%
Net margin 4.69%
Quality
61 /100
Average ROIC 6.48%
Asset turnover 0.88x
ROE 9.03%
Debt
78 /100
Low Debt/Equity 0.61x
Net debt/EBITDA 2.27x
Current ratio 2.12x
Stability
90 /100
Stable Beta 1.08x
Profitable years 5
Rev. volatility 1.81%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CLB
Online
Sector
Energy
Industry
Oil & Gas Equipment & Services
CEO
Lawrence V. Bruno
Employees
3,300
Headquarters
Houston
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report